Key result
AI-automated CCTA analysis improves major cardiovascular events prediction over Agatston score, achieving an AUC of ~0.81.
Why the study?
Current CCTA workflows are labor-intensive and rely on semiquantitative scoring systems that do not fully leverage the prognostic information available in CCTA.
Does a fully automated, explainable AI system for CCTA analysis (AI-ACA) improve prediction of major adverse cardiovascular events compared with conventional risk markers in patients undergoing CCTA?
Cohort (n=1,702)
Does a fully automated, explainable AI system for CCTA analysis (AI-ACA) improve prediction of major adverse cardiovascular events compared with conventional risk markers in patients undergoing CCTA?
A fully automated, explainable AI platform for CCTA analysis provides superior prognostic discrimination for major adverse cardiovascular events compared to the Agatston score and demographic risk markers without requiring manual intervention.
Answers are grounded in this paper and cite their sources.
May enhance MACE prediction on CCTA beyond Agatston score; leaves open prospective validation before clinical adoption.
BACKGROUND: Coronary artery disease (CAD) remains a major global cause of morbidity and mortality. Coronary computed tomography angiography (CCTA) is central to noninvasive diagnosis and risk assessment, yet current workflows are labor-intensive and depend on semiquantitative scoring systems that do not fully leverage prognostic information in CCTA. OBJECTIVES: The objectives of the study were to develop and validate a fully automated, explainable artificial intelligence (AI) system (AI-automated coronary analysis [ACA]) for comprehensive CCTA analysis to predict major adverse cardiovascular events and compare its performance with conventional risk markers. METHODS: AI-ACA automatically extracts a suite of CCTA-derived biomarkers, including stenosis severity, plaque burden, and composition; AI-derived CAD - reporting and data system (CAD-RADS) (AI-CADRADS); coronary tortuosity; and subtended myocardial mass, to generate interpretable risk estimates. In a retrospective cohort (n = 1,702), we compared AI-ACA with Agatston score, standard demographic risk markers, and AI-CADRADS. Model explainability was assessed using Shapley Additive Explanations. RESULTS: AI-ACA demonstrated higher predictive performance (area under the curve [AUC]: 0.81) than Agatston score (AUC: 0.76) and demographic markers (AUC: 0.67), and similar performance to AI-CADRADS (AUC: 0.81). AI-ACA showed better prognostic discrimination than Agatston score, reflected by a higher Harrell C-index (0.791 vs 0.742) and greater separation in event-free survival on Kaplan-Meier analysis (log-rank 31.79 vs 13.71). Shapley Additive Explanations analysis identified total plaque volume and burden, maximum stenosis severity, and AI-CADRADS as the strongest contributors to risk estimation. CONCLUSIONS: A fully automated and explainable AI platform for CCTA enables comprehensive quantitative characterization of CAD without manual intervention. Although prognostic performance was comparable to AI-CADRADS and modestly higher than Agatston score, the platform provides transparent biomarker-based risk assessment and scalable analysis that may facilitate broader clinical implementation of quantitative CCTA.
No takes yet. Share an insight, caveat, or question.
Gulsun et al. (2026) conducted a cohort in Coronary artery disease (n=1,702). AI-automated coronary analysis (AI-ACA) of CCTA vs. Agatston score, standard demographic risk markers, and AI-CADRADS was evaluated on Prediction of major adverse cardiovascular events (AUC 0.81 vs 0.76 (Agatston score) and 0.67 (demographic markers); Harrell C-index 0.791 vs 0.742). AI-automated coronary analysis of CCTA improved prediction of major adverse cardiovascular events compared with Agatston score.
Synapse has enriched 10 related papers. Consider them for comparative context: